Common use of Trial Completion Clause in Contracts

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO INC Research of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.party. b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-Protocol- required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO SPONSOR of all relevant Protocol-required data, Trial documents and Biological Samples; Samples (if applicable) and receipt of all payments due to either Party.party.\

Trial Completion. This Agreement will terminate upon Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO INC Research of all relevant Protocol-required datadata (including, without limitation, Trial Data), Trial documents and Biological Samples; and receipt of all payments due to either Party.party. a.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.b. Ukončení klinického hodnocení. Pro účely této smlouvy je klinické hodnocení považováno za dokončené po uzavření všech činností vyžadovaných protokolem pro všechny zařazené

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all Trial Data and other relevant Protocol-required data, Trial documents and Biological Samples, Trial Drug return, Trial Medication supplies return, electronically signed CRFs for all Trial Subjects, locked database, close-out and final monitoring visit; and receipt of all payments due to either Party.party pursuant to the Agreement. b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents documents, Trial Data and Biological Samples; and receipt of all payments due to either Partyparty.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-Protocol- required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.. b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO Syneos Health of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samplesb. Dokončenie skúšania. Skúšanie sa, na účely tejto zmluvy, považuje za ukončené po dokončení všetkých činností požadovaných protokolom pre všetkých účastníkov skúšania, ktorí boli zaradení do skúšania; and receipt of all payments due to either Party.po odovzdaní všetkých príslušných údajov požadovaných protokolom, dokumentov

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-Protocol- required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.party. b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-Protocol- required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. klinického hodnocení, Pro vyloučení pochybností, odškodnění podle tohoto článku 16 neomezuje žádné zákonné nároky jakékoli strany.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO Syneos Health of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.. xxxxxxxxxx

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.party. b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-Protocol- required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data18.1 Podmínky ukončení. Tato smlouva bude ukončena v těchto případech podle toho, Trial documents and Biological Samples; and receipt of all payments due to either Party.který z nich nastane dřív: a.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-Protocol- required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party.18.1 Podmínky ukončení. Tato smlouva bude ukončena v těchto případech podle toho, který z nich nastane dřív:

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. It is anticipated that the Trial shall be conducted from November 2018 to December 2022. smlouvu.